Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leah K Schutt

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of the American Association for Laboratory Animal Science : JAALAS|September 23, 2010
Microchip-associated sarcoma in a shrew (Suncus murinus)Leah K Schutt, Patricia V Turner
Journal of the American Veterinary Medical Association|October 4, 2011
Cystic ectopic lingual thyroid tissue in a male catTravis P Reed, Brigitte A Brisson, Leah K Schutt
The Journal of Pharmacology and Experimental Therapeutics|November 9, 2016
Bruton's Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in RatsRebecca I Erickson, Leah K Schutt, Jacqueline M Tarrant, et al.
JCI Insight|April 10, 2020
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibodyKarin Staflin, Christina L Zuch de Zafra, Leah K Schutt, et al.
Journal of Medicinal Chemistry|November 15, 2021
Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase InhibitorsDennis X Hu, Snahel Patel, Huifen Chen, et al.
Science Advances|May 6, 2026
Loss of the autoimmune risk gene TREX1 reveals a convergence of mechanisms promoting immune tolerance loss and antitumor immunityJunghyun Lim, Katherine Williams, Stephanie Mittman, et al.
Journal of Medicinal Chemistry|July 12, 2021
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast CancerJun Liang, Jason R Zbieg, Robert A Blake, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of the American Association for Laboratory Animal Science : JAALAS|September 23, 2010
Microchip-associated sarcoma in a shrew (Suncus murinus)Leah K Schutt, Patricia V Turner
Journal of the American Veterinary Medical Association|October 4, 2011
Cystic ectopic lingual thyroid tissue in a male catTravis P Reed, Brigitte A Brisson, Leah K Schutt
The Journal of Pharmacology and Experimental Therapeutics|November 9, 2016
Bruton's Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in RatsRebecca I Erickson, Leah K Schutt, Jacqueline M Tarrant, et al.
JCI Insight|April 10, 2020
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibodyKarin Staflin, Christina L Zuch de Zafra, Leah K Schutt, et al.
Journal of Medicinal Chemistry|November 15, 2021
Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase InhibitorsDennis X Hu, Snahel Patel, Huifen Chen, et al.
Science Advances|May 6, 2026
Loss of the autoimmune risk gene TREX1 reveals a convergence of mechanisms promoting immune tolerance loss and antitumor immunityJunghyun Lim, Katherine Williams, Stephanie Mittman, et al.
Journal of Medicinal Chemistry|July 12, 2021
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast CancerJun Liang, Jason R Zbieg, Robert A Blake, et al.
Pageof 1